GYRE Gyre Therapeutics, Inc.
$6.73▼ -0.15%
Healthcare
Other
After hours
$6.73▲ +0.00%
Sep 11, 7:30 PM ET
Volume 69.8K
Avg Volume (10D) 74.8K
Key Metrics & Fundamentals
Market Cap
$713.61M
P/E Ratio
–
Div Yield
–%
52W Range
5.44 - 9.42
% vs 50 MA
3.31%
% vs 200 MA
-5.58%
RSI-14
52.1
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.14
Free Cash Flow
-$18.01M
Gross Rev
$29.11M
Gross Profit
$26.90M
EBITDA
-$12.01M
COGS
$2.21M
Operating Exp
$40.76M
Operating Income
-$13.86M
EBIT
-$13.86M
Pretax Income
-$14.43M
Net Income
-$10.61M
EPS (Diluted)
-0.12
Price & Volume History
Loading chart…
Recent News
Gyre Therapeutics to Participate in Upcoming September Investor Conferences
GlobeNewswire · Sep 3, 2026 11:00 AM
Gyre Therapeutics, Inc. (GYRE) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 7, 2026 12:20 PM
Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update
GlobeNewswire · Aug 7, 2026 11:00 AM
Cytokinetics (CYTK) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 6, 2026 9:40 PM
Gyre Therapeutics Appoints Three New Members to its Board of Directors
GlobeNewswire · Jul 16, 2026 8:05 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See GYRE's money flow as a full page
Social Sentiment
No Reddit posts found for GYRE.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.